Last reviewed · How we verify
Moxidectin Oral Product
At a glance
| Generic name | Moxidectin Oral Product |
|---|---|
| Sponsor | Medicines Development for Global Health |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases (PHASE4)
- Efficacy and Safety Study of Moxidectin in Adults With Scabies (PHASE2)
- Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients (PHASE2)
- Dose-finding Study of Moxidectin for Treatment of Scabies (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Moxidectin Oral Product CI brief — competitive landscape report
- Moxidectin Oral Product updates RSS · CI watch RSS
- Medicines Development for Global Health portfolio CI